← Back to SLS

SELLAS Life Sciences Group, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 12/05/2026Sep 2025Filed 12/11/2025Jun 2025Filed 11/08/2026Mar 2025Filed 12/05/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 13/05/2025
−$9.6−$8.4−$6.8−$6.6−$5.8−$7.1−$7.5−$9.6
−$0.05−$0.05−$0.06−$0.07−$0.07−$0.10−$0.13−$0.21
1891721089988685845

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.